Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 67.86 M77.3 M72.55 M70.86 M 288.57 M Research & development ———— — Operating income -23.17 M40.8 M14.62 M4.29 M 36.54 M Non-Operating Income, Total ———— — Interest expense, net of interest capitalized 2.84 M2.98 M3.98 M2.49 M 12.29 M Non-Operating Income, excl. Interest Expenses ———— — Unusual income/expense ———— — Pretax income -26.91 M36.91 M9.74 M935 K 20.67 M Equity in earnings ———— — Taxes -8.64 M11.91 M3.08 M-2.55 M 3.8 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -18.27 M25 M6.66 M3.48 M 16.87 M Discontinued operations ———— — Net income -18.27 M25 M6.66 M3.48 M 16.87 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -18.23 M24.94 M6.66 M3.48 M 16.86 M Basic earnings per share (Basic EPS) -0.540.730.190.11 0.49 Diluted earnings per share (Diluted EPS) -0.540.720.190.12 0.49 Average basic shares outstanding 34.05 M34.05 M34.45 M34.33 M — Diluted shares outstanding 34.05 M34.54 M34.66 M34.61 M — EBITDA 43.61 M119.01 M88.09 M90.25 M 340.96 M EBIT 42.7 M118.1 M87.17 M75.15 M 323.11 M Cost of revenue 232.78 M514.58 M418.99 M182.25 M 1.35 B Other cost of goods sold ———— — Depreciation & amortization (cash flow) 916 K915 K915 K15.11 M 17.85 M